The global hemophilia treatment market share analysis highlights a steadily expanding healthcare segment driven by advancements in recombinant therapies, gene therapy development, and increasing diagnosis rates of bleeding disorders. Hemophilia, a rare genetic disorder that impairs the body’s ability to make blood clots, continues to require lifelong treatment, positioning the market for...